ChitogenX Inc.
CHGX
CNSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 590.60K | 645.90K | 805.30K | 1.30M | 1.42M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 976.70K | 962.80K | 1.24M | 2.03M | 2.34M |
| Operating Income | -976.70K | -962.80K | -1.24M | -2.03M | -2.34M |
| Income Before Tax | -1.14M | -1.28M | -1.34M | -1.15M | -2.41M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.14 | -1.28 | -1.34 | -1.15 | -2.41 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.14M | -1.28M | -1.34M | -1.15M | -2.41M |
| EBIT | -976.70K | -962.80K | -1.24M | -2.03M | -2.34M |
| EBITDA | -949.70K | -934.20K | -1.21M | -2.00M | -2.31M |
| EPS Basic | -0.01 | -0.02 | -0.02 | -0.01 | -0.04 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.01 | -0.04 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 332.42M | 329.62M | 323.58M | 291.49M | 259.53M |
| Average Diluted Shares Outstanding | 332.42M | 329.62M | 323.58M | 291.49M | 259.53M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
